Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/10/2002WO2002079515A1 Antisense modulation of urokinase plasminogen activator expression
10/10/2002WO2002079510A1 Gene analysis method and analyzer therefor
10/10/2002WO2002079509A1 Oligonucleotide primers for the phosphatidylinositol specific phospholipase c gene and method for the detection of bacillus cereus
10/10/2002WO2002079507A2 Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs
10/10/2002WO2002079505A2 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci
10/10/2002WO2002079499A1 Pd-1, a receptor for b7-4, and uses therefor
10/10/2002WO2002079495A2 Genomics applications for modified oligonucleotides
10/10/2002WO2002079493A2 Improved hybrid gene libraries and uses thereof
10/10/2002WO2002079492A2 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
10/10/2002WO2002079491A2 Method for correlating gene expression profiles with protein expression profiles
10/10/2002WO2002079490A2 Bio-barcodes based on oligonucleotide-modified particles
10/10/2002WO2002079487A2 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism
10/10/2002WO2002079482A2 In vitro transcribed retroviral genomes, methods for their production and methods of use
10/10/2002WO2002079481A1 Method of encoding information in nucleic acids of a genetically engineered organism
10/10/2002WO2002079480A1 Gfp expression vector localized in mitochondria
10/10/2002WO2002079479A2 Motor proteins and methods for their use
10/10/2002WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002WO2002079477A2 Biosynthetic genes for butenyl-spinosyn insecticide production
10/10/2002WO2002079476A1 Method of detecting the expression of aspergillus gene
10/10/2002WO2002079475A2 Streptococcus pyogenes antigens and corresponding dna fragments
10/10/2002WO2002079474A2 Human b7 polypeptides
10/10/2002WO2002079473A2 Molecules for diagnostics and therapeutics
10/10/2002WO2002079472A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002WO2002079471A2 Cholinesterase-anchoring protein, corresponding nucleic acids and their use for preparing medicines
10/10/2002WO2002079470A1 Disease-specific promoter chimeras for gene expression
10/10/2002WO2002079469A1 Mold polynucleotide arrays
10/10/2002WO2002079468A2 A method of increasing complementarity in a heteroduplex polynucleotide
10/10/2002WO2002079467A2 Antibiotic-free bacterial strain selection with antisense molecules
10/10/2002WO2002079466A1 Genomic dnas participating in rheumatoid arthritis, method of diagnosing the same, method of judging onset riks thereof and diagnostic kit for detecting the same
10/10/2002WO2002079465A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/10/2002WO2002079464A2 Viral vectors
10/10/2002WO2002079463A2 Methods for modification of plant inflorescence architecture
10/10/2002WO2002079461A2 Type ii thioesterase from streptomyces coelicolor a3(2) and the coding sequence
10/10/2002WO2002079453A2 Method for increasing the production of a secondary metabolite in a microorganism by introducing mutations that confer antibiotic-resistance
10/10/2002WO2002079452A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
10/10/2002WO2002079449A2 Molecules for disease detection and treatment
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079447A2 Avian lysozyme promoter
10/10/2002WO2002079446A2 Transgenic mice containing gpr31 gene disruptions
10/10/2002WO2002079445A2 Transgenic mice containing kallikrein-like gene disruptions
10/10/2002WO2002079444A2 Transgenic mice containing msk2 serine/threonine kinase gene disruptions
10/10/2002WO2002079443A2 Transgenic mice containing 5-ht5b serotonin receptor gene disruptions
10/10/2002WO2002079442A2 Transgenic mice containing ubiquitin enzyme gene disruptions
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079440A2 Transgenic mice containing gpcr5-1 gene disruptions
10/10/2002WO2002079439A2 TRANSGENIC MICE CONTAINING mGluR7 METABOTROPIC GLUTAMATE RECEPTOR GENE DISRUPTIONS
10/10/2002WO2002079438A2 Ogri gene disruptions, compositions and methods relating thereto
10/10/2002WO2002079436A2 Modulators of leukocyte activation, compositions and methods of use
10/10/2002WO2002079435A2 Transgenic mice containing gpcr-like gene disruptions
10/10/2002WO2002079434A2 Transgenic mice containing kir3.3 potassium channel gene disruptions
10/10/2002WO2002079433A2 Transgenic mice containing tmem3 beta-1,3-n-acetylglucosaminyltransferase gene disruptions
10/10/2002WO2002079432A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002WO2002079431A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/10/2002WO2002079429A2 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002WO2002079426A2 Transgenic mice containing pai3 serine protease inhibitor gene disruptions
10/10/2002WO2002079425A2 Transgenic mice containing clcn4 chloride ion channel gene disruptions
10/10/2002WO2002079424A2 TRANSGENIC MICE CONTAINING β3GALT2 GENE DISRUPTIONS
10/10/2002WO2002079423A2 Delta opioid receptor disruptions, compositions and methods related thereto
10/10/2002WO2002079422A2 Transgenic mice containing novel poz domain gene disruptions
10/10/2002WO2002079421A2 Transgenic mice containing p19-ptp protein tyrosine phosphatase gene disruptions
10/10/2002WO2002079420A2 Adam-like protease disruptions, compositions and methods related thereto
10/10/2002WO2002079419A2 Identifying and characterizing genes
10/10/2002WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002WO2002079416A2 Transgenic animals resistant to transmissible spongiform encephalopathies
10/10/2002WO2002079415A2 Reducing the immunogenicity of fusion proteins
10/10/2002WO2002079414A2 Transgenic mice containing clcn7 chloride channel gene disruptions
10/10/2002WO2002079413A2 TRANSGENIC MICE HAVING A DISRUPTION IN β-1,3,N-ACETYLGLUCOSAMINYLTRANSFERASE
10/10/2002WO2002079412A2 Transgenic mice containing usp3-like deubiquitinating enzyme gene disruptions
10/10/2002WO2002079410A2 Glucan chain length domains
10/10/2002WO2002079409A2 Integrases for the insertion of heterologous nucleic acids into the plastid genome
10/10/2002WO2002079405A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079403A2 Method for modifying plant biomass
10/10/2002WO2002079400A2 Methods for isolating genes from microorganisms
10/10/2002WO2002079399A2 Regulatable growth of filamentous fungi
10/10/2002WO2002079398A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002WO2002079395A2 Carotenoid biosynthesis
10/10/2002WO2002079393A2 Dynamic action reference tools
10/10/2002WO2002079390A2 $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof
10/10/2002WO2002079387A2 Modular molecular clasps and uses thereof
10/10/2002WO2002079380A2 Disruptions in gaba receptor rh02 subunit, methods adn uses thereof
10/10/2002WO2002079378A2 Transgenic mice containing gpcr-like transmembrane protein disruptions
10/10/2002WO2002079258A2 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
10/10/2002WO2002079257A1 Novel compound for treatment of allergy and asthma
10/10/2002WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002WO2002079252A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
10/10/2002WO2002079250A1 Insulin precursors and a process for their preparation
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079248A2 Mammalian alpha-helical protein-53
10/10/2002WO2002079245A2 Method for improving plant tolerance to environmental stress
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079242A2 Adp-ribosylating bacterial toxins
10/10/2002WO2002079241A2 Secreted streptococcus pneumoniae proteins
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079237A2 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
10/10/2002WO2002079236A1 Alpha conotoxin peptides with analgesic properties
10/10/2002WO2002079232A2 Reducing the immunogenicity of fusion proteins
10/10/2002WO2002079228A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002WO2002079227A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002WO2002079226A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
1 ... 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 ... 4023